Tata India Pharma & Healthcare Fund

Click on + to See NAV
Fund Name NAV Date NAV Rupee Change Percent Change
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option 29/Nov/2023 21.5236
0.1709
0.8004%
TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum capital withdrawal option 29/Nov/2023 21.5236
0.1709
0.8004%
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 29/Nov/2023 21.5236
0.1709
0.8004%
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option 29/Nov/2023 24.4321
0.1949
0.8041%
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option 29/Nov/2023 24.4321
0.1949
0.8041%
Tata India Pharma & Healthcare Fund-Direct Plan-Growth 29/Nov/2023 24.4321
0.1949
0.8041%

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.

Fund Performance Analysis

Tata India Pharma & Healthcare Fund Analysis

Tata India Pharma & Healthcare Fund Performance Snapshot (Regular Plan)

Rotate the phone! Best viewed in landscape mode on mobile
KPIs* Fund Cat. Avg Better Than Cat. Avg In 1st Quartile In 4th Quartile Rank (In Cat.) Min / Max
1M Return %
9.91
8.95
Yes
Yes
No
1/8 7.67 / 9.91
1M Rolling Return %
0.64
0.97
No
No
Yes
8/8 0.64 / 1.24
3M Return %
7.93
7.54
Yes
No
No
5/8 4.77 / 8.95
3M Rolling Return %
3.20
3.91
No
No
Yes
7/8 2.38 / 6.11
6M Return %
27.83
27.91
No
No
No
5/8 22.95 / 30.28
6M Rolling Return %
7.67
8.29
No
No
No
4/8 5.95 / 12.19
1Y Return %
25.57
26.43
No
No
Yes
6/8 22.61 / 29.92
1Y Rolling Return %
1.53
0.93
Yes
No
No
4/8 -2.23 / 4.10
3Y Return %
15.10
15.13
No
No
Yes
6/8 13.18 / 16.21
3Y Rolling Return %
23.17
25.05
No
No
Yes
6/7 22.80 / 28.28
5Y Return %
19.73
19.93
No
No
No
4/6 18.54 / 21.26
Standard Deviation
14.01
14.41
Yes
Yes
No
2/8 13.91 / 15.06
Semi Deviation
9.83
10.17
Yes
Yes
No
2/8 9.72 / 10.68
Max Drawdown
-15.59
-17.22
Yes
Yes
No
2/8 -19.18 / -15.43
VaR 1 Y
-15.99
-17.63
Yes
Yes
No
2/8 -19.47 / -15.67
Average Drawdown
-7.57
-7.58
Yes
No
No
3/8 -9.14 / -5.90
Sharpe Ratio
0.48
0.47
Yes
No
No
4/8 0.31 / 0.64
Sterling Ratio
0.55
0.53
Yes
No
No
4/8 0.41 / 0.65
Sortino Ratio
0.25
0.25
Yes
No
No
4/8 0.16 / 0.32
Jensen Alpha
5.52
2.27
Yes
Yes
No
1/8 -0.97 / 5.52
Treynor Ratio
0.08
0.07
Yes
No
No
4/8 0.05 / 0.10
Modigliani Square measure
15.77
15.12
Yes
No
No
4/8 12.22 / 17.98
Active Return
4.05
1.17
Yes
Yes
No
1/8 -1.69 / 4.05
Returns, performance summary of fund and return related sentences are updated daily. Last Updated On : Nov. 29, 2023.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Sept. 30, 2023 KPIs: Key Performance Indicators

Tata India Pharma & Healthcare Fund Performance vs Category Average

All parametrs are in percentage

Tata India Pharma & Healthcare Fund Performance Snapshot (Direct Plan)

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs Fund Cat. Avg Better Than Cat. Avg In 1st Quartile In 4th Quartile Rank (In Cat.) Min / Max
1M Return %
10.05
9.07
Yes
Yes
No
1/8 7.77 / 10.05
1M Rolling Return %
0.76
1.07
No
No
Yes
8/8 0.76 / 1.31
3M Return %
8.31
7.85
Yes
No
No
4/8 5.05 / 9.22
3M Rolling Return %
3.58
4.22
No
No
Yes
7/8 2.78 / 6.47
6M Return %
28.74
28.66
Yes
No
No
5/8 23.62 / 30.92
6M Rolling Return %
8.48
8.95
No
No
No
4/8 6.75 / 12.79
1Y Return %
27.44
27.93
No
No
No
5/8 24.47 / 31.06
1Y Rolling Return %
3.08
2.18
Yes
No
No
3/8 -0.82 / 5.22
3Y Return %
16.83
16.56
Yes
No
Yes
6/8 14.86 / 17.43
3Y Rolling Return %
25.06
26.65
No
No
Yes
6/7 24.07 / 30.35
5Y Return %
21.56
21.37
Yes
No
No
3/6 19.75 / 23.18
Standard Deviation
14.01
14.41
Yes
Yes
No
2/8 13.91 / 15.06
Semi Deviation
9.83
10.17
Yes
Yes
No
2/8 9.72 / 10.68
Max Drawdown
-15.59
-17.22
Yes
Yes
No
2/8 -19.18 / -15.43
VaR 1 Y
-15.99
-17.63
Yes
Yes
No
2/8 -19.47 / -15.67
Average Drawdown
-7.57
-7.58
Yes
No
No
3/8 -9.14 / -5.90
Sharpe Ratio
0.48
0.47
Yes
No
No
4/8 0.31 / 0.64
Sterling Ratio
0.55
0.53
Yes
No
No
4/8 0.41 / 0.65
Sortino Ratio
0.25
0.25
Yes
No
No
4/8 0.16 / 0.32
Jensen Alpha
5.52
2.27
Yes
Yes
No
1/8 -0.97 / 5.52
Treynor Ratio
0.08
0.07
Yes
No
No
4/8 0.05 / 0.10
Modigliani Square measure
15.77
15.12
Yes
No
No
4/8 12.22 / 17.98
Active Return
4.05
1.17
Yes
Yes
No
1/8 -1.69 / 4.05
Returns, performance summary of fund and return related sentences are updated daily. Last Updated On : Nov. 29, 2023.
Other parameters_direct, fund ranking, non return related analysis are updated after every month end. Last Updated On : Sept. 30, 2023 KPIs: Key Performance Indicators

Tata India Pharma & Healthcare Fund Regular vs Direct Plan Performance

Parameters Regular Plan Direct Plan
1M Return % 9.91% 10.05%
1M Rolling Return % 0.64% 0.76%
3M Return % 7.93% 8.31%
3M Rolling Return % 3.20% 3.58%
6M Return % 27.83% 28.74%
6M Rolling Return % 7.67% 8.48%
1Y Return % 25.57% 27.44%
1Y Rolling Return % 1.53% 3.08%
3Y Return % 15.10% 16.83%
3Y Rolling Return % 23.17% 25.06%
5Y Return % 19.73% 21.56%
Standard Deviation 14.01% 14.01%
Semi Deviation 9.83% 9.83%
Max Drawdown -15.59% -15.59%
VaR 1 Y -15.99% -15.99%
Average Drawdown -7.57% -7.57%
Sharpe Ratio 0.48% 0.48%
Sterling Ratio 0.55% 0.55%
Sortino Ratio 0.25% 0.25%
Jensen Alpha 5.52% 5.52%
Treynor Ratio 0.08% 0.08%
Modigliani Square measure 15.77% 15.77%
Active Return 4.05% 4.05%

Expected return is based on historical relationship between fund and representative benchmark. Assuming same relationsgip will hold in future.

Annulized Returns

Tata India Pharma & Healthcare Fund Expected Return

Investment Period Mini. Possible Return
in Investment Period
Max. Possible Return
in Investment Period
Expected Return
in Investment Period
Loss Probability
in Investment Period
10 Year 5.36% 18.32% 12.75% 0.00%
One Year -25.62% 80.75% 11.34% 30.12%
Three Year -11.71% 37.07% 13.59% 16.32%
Five Year -8.65% 26.24% 12.57% 7.96%
Seven Year -1.20% 23.39% 12.57% 1.62%

Expected return is based on historical relationship between fund and representative benchmark. Assuming same relationsgip will hold in future.

Annulized Returns


For Any Question Join Our Group On Facebook

Pharma Fund Category Performance Analysis

Return Chart (Regular Plan)

Click on + to See Details
Fund Name 1D Return 1W Return 1M Return 3M Return 6M Return 1Y Return 3Y Return 5Y Return
% Rank % Rank % Rank % Rank % Rank % Rank % Rank % Rank

Mirae Asset Healthcare Fund

0.85
1
-0.61
7
8.64
6
6.24
7
27.64
6
22.61
8
15.18
5
21.26
1

Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund

0.83
2
-0.27
4
9.33
3
8.09
4
29.27
3
29.92
1
16.05
3
20.86
2

Uti Healthcare Fund

0.81
3
0.32
2
9.49
2
8.95
1
30.28
1
28.01
3
13.76
7
18.54
6

Tata India Pharma & Healthcare Fund

0.80
4
0.02
3
9.91
1
7.93
5
27.83
5
25.57
6
15.10
6
19.73
4

Aditya Birla Sun Life Pharma & Healthcare Fund

0.63
5
-0.45
6
8.75
5
8.22
3
29.16
4
25.74
5
13.18
8

Nippon India Pharma Fund

0.31
6
-0.44
5
9.19
4
7.46
6
29.56
2
28.20
2
16.21
1
19.86
3

Sbi Healthcare Opportunities Fund

0.11
7
-0.64
8
7.67
8
4.77
8
22.95
8
26.33
4
16.16
2
19.34
5

Idbi Healthcare Fund

Dsp Healthcare Fund

0.60
1
8.63
7
8.65
2
26.59
7
25.02
7
15.39
4
Fund Name 1D Return 1W Return 1M Return 3M Return 6M Return 1Y Return 3Y Return 5Y Return
% Rank % Rank % Rank % Rank % Rank % Rank % Rank % Rank

Mirae Asset Healthcare Fund

0.85
1
-0.58
7
8.78
6
6.63
7
28.59
6
24.47
8
16.96
5
23.18
1

Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund

0.81
2
-0.29
4
9.43
3
8.30
5
29.75
4
31.06
1
17.09
3
22.21
2

Uti Healthcare Fund

0.81
3
0.34
2
9.58
2
9.22
1
30.92
1
29.29
3
14.98
7
19.75
6

Tata India Pharma & Healthcare Fund

0.80
4
0.05
3
10.05
1
8.31
4
28.74
5
27.44
5
16.83
6
21.56
3

Aditya Birla Sun Life Pharma & Healthcare Fund

0.63
5
-0.46
6
8.88
5
8.59
3
30.05
3
27.43
6
14.86
8

Nippon India Pharma Fund

0.32
6
-0.42
5
9.28
4
7.71
6
30.14
2
29.32
2
17.28
2
20.93
4

Sbi Healthcare Opportunities Fund

0.11
7
-0.61
8
7.77
8
5.05
8
23.62
8
27.70
4
17.43
1
20.61
5

Idbi Healthcare Fund

Dsp Healthcare Fund

0.63
1
8.76
7
9.02
2
27.46
7
26.70
7
17.02
4
Fund Name 1 Month Median Return 3 Month Median Return 6 Month Median Return 1 Year Median Return 3 Year Median Return
% Rank % Rank % Rank % Rank % Rank

Mirae Asset Healthcare Fund

0.77
7
2.38
8
5.95
8
-0.74
7
28.28
1

Dsp Healthcare Fund

1.10
3
6.11
1
11.01
2
3.37
2
27.97
2

Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund

1.24
1
4.45
2
7.65
5
1.77
3
25.09
3

Nippon India Pharma Fund

0.98
4
3.95
4
8.63
3
0.22
5
24.31
4

Sbi Healthcare Opportunities Fund

0.93
6
4.11
3
12.19
1
4.10
1
23.76
5

Tata India Pharma & Healthcare Fund

0.64
8
3.20
7
7.67
4
1.53
4
23.17
6

Uti Healthcare Fund

0.95
5
3.69
5
6.97
6
-0.60
6
22.80
7

Aditya Birla Sun Life Pharma & Healthcare Fund

1.13
2
3.39
6
6.25
7
-2.23
8
Fund Name 1 Month Median Return 3 Month Median Return 6 Month Median Return 1 Year Median Return 3 Year Median Return
% Rank % Rank % Rank % Rank % Rank

Mirae Asset Healthcare Fund

0.90
7
2.78
8
6.75
8
0.81
6
30.35
1

Dsp Healthcare Fund

1.22
3
6.47
1
11.76
2
4.81
2
30.01
2

Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund

1.31
1
4.65
2
8.16
5
2.71
4
26.50
3

Nippon India Pharma Fund

1.06
4
4.19
4
9.14
3
1.15
5
25.43
4

Sbi Healthcare Opportunities Fund

1.03
6
4.39
3
12.79
1
5.22
1
25.11
5

Tata India Pharma & Healthcare Fund

0.76
8
3.58
7
8.48
4
3.08
3
25.06
6

Uti Healthcare Fund

1.04
5
3.96
5
7.53
6
0.46
7
24.07
7

Aditya Birla Sun Life Pharma & Healthcare Fund

1.23
2
3.76
6
6.99
7
-0.82
8
Fund Name VaR 1 Y 95% Max Drawdown Average Drawdown Standard Deviation Semi Deviation
% Rank % Rank % Rank % Rank % Rank

Aditya Birla Sun Life Pharma & Healthcare Fund

-17.17
4
-18.61
7
-9.14
8
14.72
6
10.46
6

Dsp Healthcare Fund

-17.66
5
-19.18
8
-5.90
1
14.06
3
10.10
4

Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund

-17.15
3
-16.62
3
-7.92
6
14.10
4
9.72
1

Idbi Healthcare Fund

Mirae Asset Healthcare Fund

-19.47
8
-17.21
4
-7.61
4
14.98
7
10.68
8

Nippon India Pharma Fund

-15.67
1
-17.23
5
-7.87
5
15.06
8
10.50
7

Sbi Healthcare Opportunities Fund

-19.03
7
-15.43
1
-6.26
2
13.91
1
9.95
3

Tata India Pharma & Healthcare Fund

-15.99
2
-15.59
2
-7.57
3
14.01
2
9.83
2

Uti Healthcare Fund

-18.91
6
-17.92
6
-8.40
7
14.47
5
10.15
5
Fund Name Sharpe Ratio Sortino Ratio Sterling ratio Hurst Index Jensen’s Alpha Beta R2 Treynor Ratio Modigliani2 Measure Active Return
% Rank % Rank % Rank % Rank Value Rank Value Rank % Rank % Rank % Rank

Aditya Birla Sun Life Pharma & Healthcare Fund

0.31
8
0.16
8
0.41
8
0.39
-0.97
8 0.94 3
0.96
3
0.05
8
12.22
8
-1.69
8

Dsp Healthcare Fund

0.47
5
0.24
5
0.48
6
0.38
2.40
5 0.86 7
0.87
8
0.08
5
15.26
5
0.60
6

Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund

0.52
3
0.28
3
0.56
3
0.35
2.75
3 0.89 5
0.93
5
0.08
3
16.02
3
1.35
4

Idbi Healthcare Fund

Mirae Asset Healthcare Fund

0.45
6
0.23
6
0.52
5
0.36
1.19
6 0.96 2
0.96
2
0.07
6
14.45
6
0.70
5

Nippon India Pharma Fund

0.55
2
0.29
2
0.58
2
0.41
2.71
4 0.97 1
0.97
1
0.09
2
16.04
2
2.34
3

Sbi Healthcare Opportunities Fund

0.64
1
0.32
1
0.65
1
0.40
4.50
2 0.88 6
0.93
6
0.10
1
17.98
1
2.94
2

Tata India Pharma & Healthcare Fund

0.48
4
0.25
4
0.55
4
0.37
5.52
1 0.85 8
0.89
7
0.08
4
15.77
4
4.05
1

Uti Healthcare Fund

0.36
7
0.19
7
0.45
7
0.38
0.07
7 0.93 4
0.95
4
0.06
7
13.25
7
-0.90
7

Tata India Pharma & Healthcare Fund Additional Return Analysis

Tata India Pharma & Healthcare Fund Value of Investment

Plan Type 1 Day 1 Week 1 Month 3 Month 6 Month 1 Year 3 Year 5 Year
Regular Plan Value of 1000 Rupee 1008.00 1000.21 1099.12 1079.29 1278.31 1255.70 1524.68 2460.35
Direct Plan Value of 1000 Rupee 1008.04 1000.48 1100.53 1083.15 1287.42 1274.36 1594.84 2654.62
Fund Information
Fund Launch Date: 04/Dec/2015
Fund Category: Pharma Fund
Investment Objective: The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.
Fund Description: A) Pharmaceuticals and Healthcare services sector oriented Fund b) Ideal for investors seeking focused investments in Health service and Medicine realated sectors
Fund Benchmark: Nifty Pharma Total Return Index
Source: Fund FactSheet


Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.


For Any Question Join Our Group On Facebook



More Mutual Fund Analysis Article

Small cap mutual funds, as defined by SEBI and AMFI, primarily invest in companies ranked 251st onwards in terms of market capitalization. They offer high growth potential as they invest in smaller, growing companies that could yield high returns. Moreover, they can uncover undervalued stocks that are often under-researched. Small-cap funds also bounce back quickly from economic downturns due to their adaptability. However, they have drawbacks like high volatility, and liquidity risk, and require a longer investment horizon. Although they carry significant risk, with informed decision-making, a clear understanding of the risk-reward paradigm, and guidance from skilled fund managers, they can contribute significantly to wealth creation.
 

Large-cap mutual funds invest in large, established companies, offering investors the potential for consistent returns and lower risk due to their stability and diversification across sectors. These funds, managed by professional fund managers, also offer high liquidity and the potential for regular dividend payouts. However, drawbacks include limited growth potential, as these mature companies operate at or near their peak in saturated markets. Also, they aren't immune to economic downturns and offer less control to investors over their investments. The suitability of these funds depends on an individual's financial goals, risk tolerance, and investment horizon.

  1. Money market mutual funds invest in short-term, high-quality debt instruments, aiming to maintain a stable value.
  2. Advantages include safety and stability due to high-credit-rating investments, high liquidity with typically penalty-free withdrawals, diversification across various debt instruments, and modest interest earnings.
  3. Disadvantages encompass lower returns compared to riskier investments, lack of government insurance, vulnerability to inflation risk, management fees that can eat into returns, and the potential for negative yields in periods of extremely low or negative interest rates.